UAB "CSO Pharma Baltic" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 420,311 |
| 52,539 |
| 7,873 |
| -7,868 |
| -984 |
| 30.70 |
| -1.87 |
| 40,791 |
| 21,120 |
| 8,175 |
| 55,752 |
| 2024 |
|---|
| 328,261 |
| 65,391 |
| 7,322 |
| 7,322 |
| 1,459 |
| 35.02 |
| 2.23 |
| 48,163 |
| 23,845 |
| 4,404 |
| 70,187 |
| 2025 |
|---|
| 0 |
| 0 |
| 19,204 |
| -19,204 |
| -9,507 |
| - |
| - |
| 39,734 |
| 2,517 |
| 634 |
| 41,781 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 0 |
| 0 |
| 19,204 |
| -19,204 |
| -9,507 |
| - |
| - |
| 39,734 |
| 2,517 |
| 634 |
| 41,781 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
19,204 €162 % *
Net Profit (€)
-19,204 €-362 % *
Profit per employee (€)
-9,507 €-752 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
39,734 €-18 % *
Amounts Payable And Liabilities (€)
2,517 €-89 % *
Non-current Assets (€)
634 €-86 % *
CurrentAssets (€)
41,781 €-40 % *
